Abstract:Rationale In pulmonary arterial hypertension (PAH), highly proliferative microvascular endothelial cells (MVECs) are thought to contribute to vaso‐occlusive lesion formation and increased pulmonary artery pressures. Using MVECs isolated from the Sugen/Hypoxia (SuHx) model of PAH, we recently showed that increased mtROS production activates the transient receptor potential vanilloid‐4 (TRPV4) channel and contributes to increased MVEC proliferation in vitro . However, the mechanistic basis for sustained mtROS production in MVECs isolated from SuHx rats (SuHx‐MVECs) was unclear. Along with increased mtROS production, we observed evidence of significant mitochondrial dysfunction, including increased fragmentation and glycolytic shift. Since mtROS production can be regulated by shifts in TCA fuel substrates, we hypothesized that generation of TCA metabolites using non‐glucose sources (i.e. anaplerosis) could be the source of mitochondrial dysfunction and mtROS production in SuHx‐MVECs. Methods Ca 2+ was measured using Fura‐2AM loaded MVEC in a flow chamber perfused with Krebs buffer. Mitochondrial morphology was measured computationally using previously validated algorithms applied to confocal images of mitochondria in N‐ and SuHx‐MVEC treated with MitoTracker. ROS measurements were made using the ratiometric ROS sensor roGFP. Lipid droplets were assessed using BODIPY staining in live MVECs, and quantified using CellProfiler. Targeted metabolomics were conducted using a standardized LC/MS approach and MS‐grade reagent standards. Results Despite evidence of glycolytic shift (decreased oxygen consumption rate, increased extracellular acidification rate, increased extracellular lactate levels), levels of TCA metabolites (measuring using targeted metabolomics) were not significantly lower in SuHx‐MVECs compared to normoxic (N‐MVEC) controls, suggesting presence of significant anaplerosis. Serum free fatty acids (FFA) were increased in SuHx rats at 5 weeks. Intracellular lipid droplet number was increased in SuHx‐MVECs, while droplet size was decreased, suggesting increased FA utilization. Untargeted metabolomics performed in N‐MVEC and SuHx‐MVEC cell extracts revealed evidence of metabolite shunting towards nucleotide and amino acid synthesis as well as increased levels of fatty acid oxidation byproducts. In cultured SuHx‐MVECs, inhibition of mitochondrial fatty acid import (with Etoximir) attenuated basal Ca 2+ and mitochondrial fragmentation to a similar extent as mtROS quenching and TRPV4 inhibition. Conclusion Increased utilization of fatty acid oxidation for anaplerotic carbons is associated with mitochondrial fragmentation and mtROS production, which in turn increases [Ca 2+ ] I via a TRPV4‐dependent mechanism. These data suggest a novel link between EC metabolism, mitochondrial dysfunction and TRPV4 activation in the SuHx model of PAH. Support or Funding Information This work was supported by by the National Heart, Lung and Blood Institute Grants F32HL124930 and K08HL132055 (KS), R01HL073859, R25HL084762 and R01HL126514 (LAS), F32HL124727, and K08HL133475 (JH) and T32HL007534 (KS and JH).

Role of Mitochondrial Reactive Oxygen Species (ROS) and TRPV4 Activation in Microvascular Endothelial Cell Dysfunction in PAH.

Mitochondrial ROS (mtros) Production and TRPV4 Translocation/activation in Lung Microvascular Endothelial Cells

Metabolic Regulation of Mitochondrial Reactive Oxygen Species (mtros) Production and Transient Receptor Potential Vanilloid‐4 (TRPV4) Activation in Microvascular Endothelial Cells in PAH

Increased fatty acid oxidation promotes mitochondrial ROS (mtROS) production and Ca 2+ entry via TRPV4 in microvascular endothelial cells in PAH

Reactive oxygen species induced Ca2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.

Mitochondrial ROS Production in Lung Microvascular Endothelial Cells Sensitizes the Transient Receptor Potential Vanilloid‐4 (TRPV4) Channel to Physical and Chemical Stimuli.

Regulation of Mitochondrial Fragmentation in Microvascular Endothelial Cells Isolated from the SU5416/hypoxia Model of Pulmonary Arterial Hypertension.

Fatty Acid Metabolism Promotes TRPV4 Activity in Lung Microvascular Endothelial Cells in Pulmonary Arterial Hypertension.

Aquaporin 1 Mediates Microvascular Endothelial Dysfunction in the SU5416/hypoxia Model of Pulmonary Hypertension

Hypoxia-Induced Mitochondrial ROS and Function in Pulmonary Arterial Endothelial Cells

Upregulation of Aquaporin 1 Mediates Increased Migration and Proliferation in Pulmonary Vascular Cells from the Rat SU5416/Hypoxia Model of Pulmonary Hypertension

Mitochondrial ROS, uncoupled from ATP synthesis, determine endothelial activation for both physiological recruitment of patrolling cells and pathological recruitment of inflammatory cells.

Abstract P141: Aging in Mice Enhances Microvascular Reactive Oxygen Species (ROS) That Impair the Anti-Contractile Actions of Perivascular Adipose Tissue (PVAT)

Metabolic reprogramming, oxidative stress, and pulmonary hypertension

Vascular peroxidase 1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation, apoptosis resistance and migration

Reactive Oxygen Species-Induced TRPM2-Mediated Ca2+ Signalling in Endothelial Cells

Regulation of endothelial cell mitochondrial phenotype by mechanosensitive ion channel TRPV4

Abstract 659: Plasminogen Activator Inhibitor-1 (PAI-1) Increases Mitochondrial Membrane Potential In Vascular Smooth Muscle Cells And Coronary Arteries

The Na+/H+ Exchanger Contributes To Increased Smooth Muscle Proliferation And Migration In A Rat Model Of Pulmonary Arterial Hypertension

Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension

Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to the Development of Pulmonary Arterial Hypertension.